Citius Oncology, Inc. CTOR Change in Prepaids
Change in Prepaids at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.
The official record: Citius Oncology, Inc.’s 10-Q, filed February 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s change in prepaids.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Citius Oncology, Inc.'s change in prepaids?
- Citius Oncology, Inc. (CTOR) reported change in prepaids of $1.83M in Q4 2025.
- What does change in prepaids mean?
- Represents the net change in prepaid expenses and other current assets during the reporting period. An increase in this metric indicates that the company has paid for goods or services in advance, which consumes cash, while a decrease indicates the consumption of those assets. It is a critical component of the cash flow from operations reconciliation.